ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
83,015
-0,13%
Bitcoin
63 824,69
-0,27%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Xenetic Biosciences Inc (XBIO)

  7. Xenetic Biosciences Inc (XBIO) Actualités

XBIO

Xenetic Biosciences (XBIO)

Xenetic Biosciences Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:XBIO
DateHeureSourceTitreSymboleSociété
12/02/202415h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XBIOXenetic Biosciences Inc
18/12/202323h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XBIOXenetic Biosciences Inc
18/12/202323h16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XBIOXenetic Biosciences Inc
13/11/202323h06Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:XBIOXenetic Biosciences Inc
13/11/202323h00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:XBIOXenetic Biosciences Inc
09/11/202323h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XBIOXenetic Biosciences Inc
18/09/202318h21Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:XBIOXenetic Biosciences Inc
15/06/202323h21Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:XBIOXenetic Biosciences Inc
02/06/202314h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XBIOXenetic Biosciences Inc
11/05/202322h31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XBIOXenetic Biosciences Inc
22/03/202321h32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:XBIOXenetic Biosciences Inc
09/12/202223h05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XBIOXenetic Biosciences Inc
10/11/202215h35TipRanksH.C. Wainwright Keeps Their Buy Rating on Xenetic Biosciences (XBIO)NASDAQ:XBIOXenetic Biosciences Inc
21/10/202222h21Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:XBIOXenetic Biosciences Inc
17/10/202223h02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:XBIOXenetic Biosciences Inc
03/10/202223h13Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:XBIOXenetic Biosciences Inc
13/05/202212h36TipRanksXenetic Biosciences (XBIO) Gets a Buy Rating from H.C. WainwrightNASDAQ:XBIOXenetic Biosciences Inc
02/05/202212h17TipRanksH.C. Wainwright Maintains Their Buy Rating on Xenetic Biosciences (XBIO)NASDAQ:XBIOXenetic Biosciences Inc
28/04/202222h33Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:XBIOXenetic Biosciences Inc
28/04/202212h25TipRanksH.C. Wainwright Thinks Xenetic Biosciences’ Stock is Going to RecoverNASDAQ:XBIOXenetic Biosciences Inc
30/12/202122h32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:XBIOXenetic Biosciences Inc
19/11/202122h55Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:XBIOXenetic Biosciences Inc
25/10/202112h03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:XBIOXenetic Biosciences Inc
20/10/202122h31Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:XBIOXenetic Biosciences Inc
15/10/202123h00Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:XBIOXenetic Biosciences Inc
12/10/202123h25Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:XBIOXenetic Biosciences Inc
23/10/201922h25Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:XBIOXenetic Biosciences Inc
30/09/201923h35Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:XBIOXenetic Biosciences Inc
22/07/201922h20Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)NASDAQ:XBIOXenetic Biosciences Inc
22/07/201922h00Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)NASDAQ:XBIOXenetic Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:XBIO

Dernières Valeurs Consultées

EU
RNO
Renault
EU
PX4
SBF 120
EU
AI
Air Liquide
EU
VK
Vallourec
SPI
SP500
S&P 500
EU
BN
Danone
EU
PX1
CAC 40
NYSE
DIS
Walt Disney
EU
ML
Michelin
NASDAQ
AAPL
Apple
EU
HO
Thales
EU
CAP
Capgemini
NASDAQ
GOOGL
Alphabet
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés